Th17 cells, Job's syndrome and HIV: Opportunities for bacterial and fungal infections

Current Opinion in HIV and AIDS

Volumn 5, Issue 2, 2010, Pages 179-183

  Milner, Joshua D ^a   Sandler, Netanya G ^b   Douek, Daniel C ^b  

^a Laboratory of Allergic Diseases   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

HIV; Hyper IgE syndrome; Job's syndrome; STAT3; Th17

Indexed keywords

ANTIRETROVIRUS AGENT; CASPASE RECRUITMENT DOMAIN PROTEIN 9; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; CYTOKINE; DECTIN 1; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; PROTEIN DOCK 8; PROTEIN KINASE; PROTEIN KINASE TYK2; STAT3 PROTEIN; UNCLASSIFIED DRUG;

BACTERIAL INFECTION; BLOOD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CYTOKINE PRODUCTION; DIGEORGE SYNDROME; DISEASE COURSE; GASTROINTESTINAL TRACT; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPER IGE SYNDROME; IMMUNE RESPONSE; LOSS OF FUNCTION MUTATION; MUCOCUTANEOUS CANDIDIASIS; MYCOSIS; NETHERTON DISEASE; NONHUMAN; OMENN SYNDROME; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RHESUS MONKEY; SIGNAL TRANSDUCTION; SIMIAN IMMUNODEFICIENCY VIRUS; TH17 CELL; VIRUS LOAD; VIRUS REPLICATION; WISKOTT ALDRICH SYNDROME;

CARD SIGNALING ADAPTOR PROTEINS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-1BETA; INTERLEUKIN-23; INTERLEUKIN-6; JOB'S SYNDROME; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, HELPER-INDUCER; TYK2 KINASE;

EID: 76949088006     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e328335ed3e     Document Type: Review

References (66)

1. Davis S, Schaller J, Wedgwood R. Job's syndrome. Recurrent, 'cold', staphylococcal abscesses. Lancet 1966; 1:1013-1015.
2. Buckley RH, Wray BB, Belmaker EZ. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics 1972; 49:59-70.
3. Ling JC, Freeman AF, Gharib AM, et al. Coronary artery aneurysms in patients with hyper IgE recurrent infection syndrome. Clin Immunol 2007; 122:255-258.
4. Grimbacher B, Holland SM, Gallin JI, et al. Hyper-IgE syndrome with recurrent infections: an autosomal dominant multisystem disorder. N Engl J Med 1999; 340:692-702.
5. Domingo DL, Freeman AF, Davis J, et al. Novel intraoral phenotypes in hyperimmunoglobulin-E syndrome. Oral Dis 2008; 14:73-81.
6. FreemanAF, Collura-Burke CJ, PatronasNJ, et al. Brain abnormalities in patients with hyperimmunoglobulin E syndrome. Pediatrics 2007; 119:e1121-e1125.
7. Minegishi Y, Saito M, Tsuchiya S, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 2007; 448:1058-1062.
8. Holland SMDF, Elloumi HZ, Hsu AP, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 2007; 357:1608-1619.
9. Grimbacher B, Schaffer AA, Holland SM, et al. Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet 1999; 65:735-744.
10. Ozcan E, Notarangelo LD, Geha RS. Primary immune deficiencies with aberrant IgE production. J Allergy Clin Immunol 2008; 122:1054-1062; quiz 1063-11054
11. Renner ED, Puck JM, Holland SM, et al. Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr 2004; 144:93-99.
12. Minegishi Y, Saito M, Morio T, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 2006; 25:745-755.
13. Zhang Q, Davis JC, Lamborn IT, et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med 2009; 361:2046-2055.
14. Melia E, Freeman AF, Shea YR, et al. Pulmonary nontuberculous mycobacterial infections in hyper-IgE syndrome. J Allergy Clin Immunol 2009; 124: 617-618.
15. Al Khatib S, Keles S, Garcia-Lloret M, et al. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome. J Allergy Clin Immunol 2009; 124:342-348; 348 e341-345..
16. Wjst M, Lichtner P, Meitinger T, Grimbacher B. STAT3 single-nucleotide polymorphisms and STAT3 mutations associated with hyper-IgE syndrome are not responsible for increased serum IgE serum levels in asthma families. Eur J Hum Genet 2009; 17:352-356.
17. Milner JD, Brenchley JM, Laurence A, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008; 452:773-776.
18. Ma CS, Chew GY, Simpson N, et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med 2008; 205:1551-1557.
19. de Beaucoudrey L, Puel A, Filipe-Santos O, et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med 2008; 205:1543-1550.
20. Glocker EO, Hennigs A, Nabavi M, et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 2009; 361:1727-1735.
21. Ferwerda B, Ferwerda G, Plantinga TS, et al. Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 2009; 361:1760-1767.
22. Conti HR, Shen F, Nayyar N, et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009; 206:299-311.
23. Fossiez F, Djossou O, Chomarat P, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 1996; 183:2411-2415.
24. Jones C, Chan K. Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells. Am J Respir Cell Mol Biol 2002; 26:748-753.
25. Kawaguchi M, Kokubu F, Kuga H, et al. Modulation of bronchial epithelial cells by IL-17. J Allergy Clin Immunol 2001; 108:804-809.
26. Laan M, Cui Z, Hoshino H, et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 1999; 162:2347-2352.
27. Lehrer R, Cline M. Interaction of Candida albicans with human leukocytes and serum. J Bacteriol 1969; 98:996-1004.
28. Nauseef W. How human neutrophils kill and degrade microbes: an integrated view. Immunol Rev 2007; 219:88-102.
29. Urban C, Ermert D, Schmid M, et al. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog 2009; 5:e1000639.
30. Anwar S, Prince L, Foster S, et al. The rise and rise of Staphylococcus aureus: laughing in the face of granulocytes. Clin Exp Immunol 2009; 157:216-224.
31. Pappas P, Kauffman C, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:503-535.
32. Antachopoulos C, Walsh T, Roilides E. Fungal infections in primary immunodeficiencies. Eur J Pediatr 2007; 166:1099-1117.
33. Hill H, Ochs H, Quie P, et al. Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent 'cold' staphylococcal abscesses. Lancet 1974; 2:617-619.
34. Paslin D, Norman M. Atopic dermatitis and impaired neutrophil chemotaxis in Job's syndrome. Arch Dermatol 1977; 113:801-805.
35. Donabedian H, Gallin J. The hyperimmunoglobulin E recurrent-infection (Job's) syndrome. A review of the NIH experience and the literature. Medicine 1983; 62:195-208.
36. Minegishi Y, Saito M, Nagasawa M, et al. Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome. J Exp Med 2009; 206:1291-1301.
37. Wolk K, Kunz S, Witte E, et al. IL-22 increases the innate immunity of tissues. Immunity 2004; 21:241-254.
38. Eyerich K, Foerster S, Rombold S, et al. Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J Invest Dermatol 2008; 128:2640-2645.
39. Glocker EO, Kotlarz D, Boztug K, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 2009; 361: 2033-2045.
40. Speckmann C, Enders A, Woellner C, et al. Reduced memory B cells in patients with hyper IgE syndrome. Clin Immunol 2008; 129:448-454.
41. Sheerin K, Buckley R. Antibody responses to protein, polysaccharide, and phi X174 antigens in the hyperimmunoglobulinemia E (hyper-IgE) syndrome. J Allergy Clin Immunol 1991; 87:803-811.
42. Eddahri F, Denanglaire S, Bureau F, et al. Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities. Blood 2009; 113:2426-2433.
43. Nurieva RI, Chung Y, Hwang D, et al. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 2008; 29:138-149.
44. Johnston RJ, Poholek AC, DiToro D, et al. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 2009; 325:1006-1010.
45. Yu D, Rao S, Tsai LM, et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 2009; 31:457-468.
46. Nurieva RI, Chung Y, Martinez GJ, et al. Bcl6 mediates the development of T follicular helper cells. Science 2009; 325:1001-1005.
47. Schmitt N, Morita R, Bourdery L, et al. Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12. Immunity 2009; 31:158-169.
48. Ma CS, Suryani S, Avery DT, et al. Early commitment of naive human CD4(+) T cells to the T follicular helper (T(FH)) cell lineage is induced by IL-12. Immunol Cell Biol 2009; 87:590-600.
49. Kaplan J, Benson C, Holmes K, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58:1-207.
50. Laupland K, Ross T, Gregson D. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J Infect Dis 2008; 198:336-343.
51. Crum-Cianflone N, Burgi A, Hale B. Increasing rates of community-acquired methicillin-resistant Staphylococcus aureus infections among HIV-infected persons. Int J STD AIDS 2007; 18:521-526.
52. Crum-Cianflone N, Weekes J, Bavaro M. Recurrent community-associated methicillin-resistant Staphylococcus aureus infections among HIV-infected persons: incidence and risk factors. AIDS Patient Care STDS 2009; 23:499-502.
53. Freeman A, Davis J, Anderson V, et al. Pneumocystis jiroveci infection in patients with hyper-immunoglobulin E syndrome. Pediatrics 2006; 118:e1271-e1275.
54. Brenchley J, Paiardini M, Knox K, et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 2008; 112: 2826-2835.
55. Cecchinato V, Trindade C, Laurence A, et al. Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal Immunol 2008; 1:279-288.
56. Raffatellu M, Santos R, Verhoeven D, et al. Simian immunodeficiency virusinduced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 2008; 14:421-428.
57. Brenchley J, Price D, Schacker T, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-1371.
58. Zhang Z, Clarke T, Weiser J. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 2009; 119: 1899-1909.
59. Rudner X, Happel K, Young E, Shellito J. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect Immun 2007; 75:3055-3061.
60. Macal M, Sankaran S, Chun T, et al. Effective CD4+ T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses. Mucosal Immunol 2008; 1:475-488.
61. Elsaesser H, Sauer K, Brooks DG. IL-21 is required to control chronic viral infection. Science 2009; 324:1569-1572.
62. Frohlich A, Kisielow J, Schmitz I, et al. IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science 2009; 324:1576-1580.
63. Yi JS, Du M, Zajac AJ. A vital role for interleukin-21 in the control of a chronic viral infection. Science 2009; 324:1572-1576.
64. Kallies A, Xin A, Belz GT, Nutt SL. Blimp-1 transcription factor is required for the differentiation of effector CD8(+) T cells and memory responses. Immunity 2009; 31:283-295.
65. Rutishauser RL, Martins GA, Kalachikov S, et al. Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity 2009; 31: 296-308.
66. Shin H, Blackburn SD, Intlekofer AM, et al. A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection. Immunity 2009; 31:309-320.